|More codeine fatalities after tonsillectomy in North American children|
LE Kelly, M Rieder, J van den Anker, B Malkin, C Ross, MN Neely, ...
Pediatrics 129 (5), e1343-e1347, 2012
|Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case–control study|
P Madadi, CJD Ross, MR Hayden, BC Carleton, A Gaedigk, JS Leeder, ...
Clinical Pharmacology & Therapeutics 85 (1), 31-35, 2009
|Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children|
H Visscher, CJD Ross, SR Rassekh, A Barhdadi, MP Dubé, H Al-Saloos, ...
Journal of Clinical Oncology 30 (13), 1422-1428, 2012
|Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy|
CJD Ross, H Katzov-Eckert, MP Dubé, B Brooks, SR Rassekh, ...
Nature genetics 41 (12), 1345-1349, 2009
|Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia|
LA Magee, S Miremadi, J Li, C Cheng, MHH Ensom, B Carleton, AM Côté, ...
American journal of obstetrics and gynecology 193 (1), 153-163, 2005
|Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin|
LR Brunham, PJ Lansberg, L Zhang, F Miao, C Carter, GK Hovingh, ...
The pharmacogenomics journal 12 (3), 233-237, 2012
|Sildenafil citrate therapy for severe early‐onset intrauterine growth restriction|
P Von Dadelszen, S Dwinnell, LA Magee, BC Carleton, A Gruslin, B Lee, ...
BJOG: An International Journal of Obstetrics & Gynaecology 118 (5), 624-628, 2011
|Thiazolidinediones and fractures in men and women|
CR Dormuth, G Carney, B Carleton, K Bassett, JM Wright
Archives of internal medicine 169 (15), 1395-1402, 2009
|Recommendations for HLA‐B* 15: 02 and HLA‐A* 31: 01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions|
U Amstutz, NH Shear, MJ Rieder, S Hwang, V Fung, H Nakamura, ...
Epilepsia 55 (4), 496-506, 2014
|A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer|
F Aminkeng, AP Bhavsar, H Visscher, SR Rassekh, Y Li, JW Lee, ...
Nature genetics 47 (9), 1079-1084, 2015
|Beta-blocker use and COPD mortality: a systematic review and meta-analysis|
M Etminan, S Jafari, B Carleton, JM FitzGerald
BMC pulmonary medicine 12 (1), 1-6, 2012
|A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children|
BR Del Pozzo-Magana, A Lazo-Langner, B Carleton, LI Castro-Pastrana, ...
Journal of population therapeutics and clinical pharmacology 18 (1), 2011
|Direct health care costs associated with asthma in British Columbia|
M Sadatsafavi, L Lynd, C Marra, B Carleton, WC Tan, S Sullivan, ...
Canadian respiratory journal 17 (2), 74-80, 2010
|Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity|
F Aminkeng, CJD Ross, SR Rassekh, S Hwang, MJ Rieder, AP Bhavsar, ...
British journal of clinical pharmacology 82 (3), 683-695, 2016
|Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline‐induced cardiotoxicity in children|
H Visscher, CJD Ross, SR Rassekh, GSS Sandor, HN Caron, ...
Pediatric blood & cancer 60 (8), 1375-1381, 2013
|Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin‐Induced Hearing Loss in Children|
K Pussegoda, CJ Ross, H Visscher, M Yazdanpanah, B Brooks, ...
Clinical Pharmacology & Therapeutics 94 (2), 243-251, 2013
|Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia|
J Lam, L Kelly, C Ciszkowski, MLA Landsmeer, M Nauta, BC Carleton, ...
The Journal of pediatrics 160 (1), 33-37. e2, 2012
|Phenotype standardization for immune‐mediated drug‐induced skin injury|
M Pirmohamed, PS Friedmann, M Molokhia, YK Loke, C Smith, E Phillips, ...
Clinical Pharmacology & Therapeutics 89 (6), 896-901, 2011
|Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update|
EJ Phillips, C Sukasem, M Whirl‐Carrillo, DJ Müller, HM Dunnenberger, ...
Clinical Pharmacology & Therapeutics 103 (4), 574-581, 2018
|HLA‐A* 31: 01 and HLA‐B* 15: 02 as genetic markers for carbamazepine hypersensitivity in children|
U Amstutz, CJD Ross, LI Castro‐Pastrana, MJ Rieder, NH Shear, ...
Clinical Pharmacology & Therapeutics 94 (1), 142-149, 2013